Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
1.710
-0.090 (-5.00%)
At close: Aug 29, 2025, 4:00 PM
1.780
+0.070 (4.09%)
After-hours: Aug 29, 2025, 7:59 PM EDT
Rockwell Medical Market Cap
Rockwell Medical has a market cap or net worth of $58.88 million as of August 29, 2025. Its market cap has decreased by -19.57% in one year.
Market Cap
58.88M
Enterprise Value
54.46M
1-Year Change
-19.57%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since December 1, 1998, Rockwell Medical's market cap has increased from $7.80M to $58.88M, an increase of 654.82%. That is a compound annual growth rate of 7.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 29, 2025 | 58.90M | -10.62% |
Dec 31, 2024 | 65.90M | 22.49% |
Dec 29, 2023 | 53.80M | 355.93% |
Dec 30, 2022 | 11.80M | -69.35% |
Dec 31, 2021 | 38.50M | -59.26% |
Dec 31, 2020 | 94.50M | -39.46% |
Dec 31, 2019 | 156.10M | 21.20% |
Dec 31, 2018 | 128.80M | -57.24% |
Dec 29, 2017 | 301.20M | -10.76% |
Dec 30, 2016 | 337.50M | -35.47% |
Dec 31, 2015 | 523.00M | 16.69% |
Dec 31, 2014 | 448.20M | 7.33% |
Dec 31, 2013 | 417.60M | 143.50% |
Dec 31, 2012 | 171.50M | 8.48% |
Dec 30, 2011 | 158.10M | 14.57% |
Dec 31, 2010 | 138.00M | 5.18% |
Dec 31, 2009 | 131.20M | 126.21% |
Dec 31, 2008 | 58.00M | -30.54% |
Dec 31, 2007 | 83.50M | 2.08% |
Dec 29, 2006 | 81.80M | 108.14% |
Dec 30, 2005 | 39.30M | 46.10% |
Dec 31, 2004 | 26.90M | -20.88% |
Dec 31, 2003 | 34.00M | 608.33% |
Dec 31, 2002 | 4.80M | -47.25% |
Dec 31, 2001 | 9.10M | 152.78% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 657.06B |
Johnson & Johnson | 423.72B |
AbbVie | 369.99B |
UnitedHealth Group | 275.29B |
Novo Nordisk | 249.87B |
AstraZeneca | 247.41B |
Novartis AG | 245.07B |
Abbott Laboratories | 229.51B |